Turk Ilac ve Serumnayi (IST:TRILC) EPS (Basic): ₺-0.44 (TTM As of Sep. 2025)


IST:TRILC Turk Ilac ve Serum Sanayi IST:TRILC
61 GF Score
Price ₺1.18
GF Value ₺3.60
Valuation Possible Value Trap
! 11 Warning Signs
View Full Analysis

What is Turk Ilac ve Serumnayi EPS (Basic)?

Turk Ilac ve Serumnayi IST:TRILC -2.48% 61 EPS (Basic) is ₺-0.44 as of Sep. 2025. GuruFocus rates IST:TRILC with a GF Score™ of 61/100 and a GF Value™ of ₺3.60 (Possible Value Trap). The stock has 11 warning signs investors should review.

Turk Ilac ve Serumnayi's basic earnings per share (Basic EPS) for the three months ended in Sep. 2025 was ₺0.12. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Sep. 2025 was ₺-0.44.

Turk Ilac ve Serumnayi's EPS (Diluted) for the three months ended in Sep. 2025 was ₺0.12. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Sep. 2025 was ₺-0.44.

Turk Ilac ve Serumnayi's EPS without NRI for the three months ended in Sep. 2025 was ₺0.11. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Sep. 2025 was -0.44.

During the past 12 months, Turk Ilac ve Serumnayi's average EPS without NRIGrowth Rate was -103.60% per year. During the past 3 years, the average EPS without NRI Growth Rate was 17.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 5 years, Turk Ilac ve Serumnayi's highest 3-Year average EPS without NRI Growth Rate was 68.10% per year. The lowest was 17.20% per year. And the median was 42.65% per year.

Turk Ilac ve Serumnayi  (IST:TRILC) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Turk Ilac ve Serumnayi EPS (Basic) Related Terms

Turk Ilac ve Serumnayi EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Turk Ilac ve Serumnayi's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Turk Ilac ve Serumnayi EPS (Basic) Chart

Turk Ilac ve Serumnayi Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
EPS (Basic)
0.03 0.04 -0.08 0.15 0.07

Turk Ilac ve Serumnayi Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -0.02 -0.29 -0.24 0.12
IST:TRILC
61GF Score
Turk Ilac ve Serum Sanayi IST:TRILC
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Turk Ilac ve Serumnayi EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Turk Ilac ve Serumnayi's Basic EPS for the fiscal year that ended in Dec. 2024 is calculated as

Basic EPS (A: Dec. 2024 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(72.359-0)/1037.000
=0.07

Turk Ilac ve Serumnayi's Basic EPS for the quarter that ended in Sep. 2025 is calculated as

Basic EPS (Q: Sep. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(119.007-0)/1030.691
=0.12

EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₺-0.44

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of ₺-0.44 mean?
Turk Ilac ve Serumnayi (IST:TRILC) has a EPS (Basic) of ₺-0.44 as of Sep. 2025. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Turk Ilac ve Serumnayi and its competitors.
Is Turk Ilac ve Serumnayi's EPS (Basic) too high?
Turk Ilac ve Serumnayi's current EPS (Basic) is ₺-0.44. Overall, Turk Ilac ve Serumnayi has a GF Score™ of 61/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Turk Ilac ve Serumnayi's EPS (Basic) compare to ZTS and UTHR?
Turk Ilac ve Serumnayi's EPS (Basic) of ₺-0.44 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Drug Manufacturers company?
A good EPS (Basic) depends on the Drug Manufacturers industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Turk Ilac ve Serumnayi and its competitors. Turk Ilac ve Serumnayi's current EPS (Basic) is ₺-0.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Turk Ilac ve Serumnayi stock overvalued right now?
Based on GuruFocus' analysis, Turk Ilac ve Serumnayi (IST:TRILC) is currently considered Possible Value Trap. The stock's GF Value™ is ₺3.60, compared to a current price of ₺1.18 — trading 67.2% below its estimated fair value. The current EPS (Basic) is ₺-0.44. Turk Ilac ve Serumnayi's overall GF Score™ is 61/100 with 11 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Turk Ilac ve Serumnayi (IST:TRILC), the current EPS (Basic) is ₺-0.44 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Turk Ilac ve Serumnayi (IST:TRILC) Overvalued in 2026?

Based on GuruFocus' analysis, Turk Ilac ve Serumnayi stock appears to be undervalued. The current stock price of ₺1.18 is trading 67.2% below its estimated GF Value™ of ₺3.60. GuruFocus considers Turk Ilac ve Serumnayi to be Possible Value Trap.

Key valuation signals for IST:TRILC:

  • EPS (Basic): ₺-0.44
  • GF Value™: ₺3.60 vs. price of ₺1.18 (67.2% below fair value)
  • GF Score™: 61/100 with 11 warning signs

No single metric tells the full story. See the IST:TRILC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Turk Ilac ve Serumnayi Business Description

Address Bugduz Mahalle Enver Pasa Cadde, No: 8 Akyurt, Ankara, TUR, TR 06750
Turk Ilac ve Serum Sanayi is engaged in the production of human pharmaceuticals and vaccines.
61GF Score

Get the complete analysis for IST:TRILC

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₺1.18
Price
₺3.60
GF Value